project id: TCGA-SARC; case submitter id: TCGA-HB-A43Z; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 8.8; age at index: 58; days to birth: -21233; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 21233; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1126.0; icd 10 code: C55; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Uterus, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Uterus, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 49; days to sample procurement: 0; initial weight: 910.0; portion submitter id: TCGA-HB-A43Z-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;